Target intelligence / Profile preview

RNA, U6 small nuclear 72, pseudogene (RNU6-72P)

Target
RNU6-72P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA) pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 72, pseudogene (RNU6-72P, LOC124902815), is annotated as a non-functional copy (pseudogene) of the U6 small nuclear RNA gene family[1][3]. U6 snRNA is a critical component of the spliceosome, where it mediates splicing of pre-mRNA by helping to catalyze the removal of introns[5][7]. While U6 snRNA is essential for splicing, RNU6-72P does not code for a functional RNA product and is not involved in catalysis or direct regulation. Like other snRNA pseudogenes, RNU6-72P may represent an evolutionary remnant and is not known to have a direct biological or therapeutic function[1][3]. Pseudogenes more broadly have been described as modulators of gene expression through antisense RNA, small interfering RNA (siRNA), microRNA competition, or as long non-coding RNAs; however, there are no reports linking RNU6-72P specifically to any regulatory function or disease role[2][4][6]. Key points: - RNU6-72P is a not a therapeutic target, enzyme, receptor, or functional non-coding RNA[1][3]. - No drugs, biomarkers, or known safety implications are associated with RNU6-72P. - The gene is best classified as a **pseudogene** with no confirmed function in human disease or therapy. If you require information on functional U6 snRNA or spliceosome biology, see the U6 snRNA entry[5][7].

Other names
RNU6-72LOC124902815
02

Biological functions

None confirmed for RNU6-72P itself; parental U6 snRNA involved in pre-mRNA splicing in eukaryotes[5][7]Pseudogenes in general may act as regulators through RNA-based mechanisms, such as miRNA decoys or sources of siRNAs[2][4][6]
03

Disease associations

None established for RNU6-72Psome pseudogenes are implicated in cancer and gene regulation[2][4][6]

Beyond the preview

Go deeper on RNA, U6 small nuclear 72, pseudogene (RNU6-72P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 72, pseudogene (RNU6-72P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call